

In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say
The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half of the security council’s staff have been laid off or left. This is dangerous say former health security officials.

Whole Eye Transplantation is No Longer Just Science Fiction
The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation.

Metsera’s Amylin Drug Looks Good in Phase 1, Shows Potential to be a Once-Monthly Obesity Med
Novo Nordisk, AbbVie, and Roche each have weekly injectable drug candidates designed to bind to and activate the amylin receptor to trigger weight loss. Metsera’s contender, MET-233i, is designed with technology that enables longer dosing intervals and the company is proceeding with development of this engineered peptide as a monotherapy and as part of a drug combination.

The Hidden Frontline of Public Health: How EMS Data Is Powering a New Era of Syndromic Surveillance
EMS data is often the earliest signal of a looming public health crisis. By tapping into it in real time, agencies can detect overdose spikes, respiratory surges, or behavioral health trends days before traditional systems catch up.